VU-0029767
VU-0029767 is a chemical compound that acts as a selective positive allosteric modulator of the muscarinic acetylcholine receptor subtype M4. It has been primarily used in scientific research to explore the role of M4 receptors in the central nervous system and their potential therapeutic applications.
Pharmacology[edit | edit source]
VU-0029767 enhances the activity of the M4 muscarinic receptor, which is a G protein-coupled receptor (GPCR) involved in various neurological processes. The M4 receptor is predominantly expressed in the striatum, a brain region associated with motor control and cognitive functions. By modulating this receptor, VU-0029767 can influence neurotransmitter release and neuronal excitability.
Mechanism of Action[edit | edit source]
As a positive allosteric modulator, VU-0029767 binds to a site on the M4 receptor distinct from the orthosteric site where the endogenous ligand, acetylcholine, binds. This binding enhances the receptor's response to acetylcholine, increasing its efficacy and potency. This mechanism allows for more precise modulation of receptor activity compared to direct agonists.
Research Applications[edit | edit source]
VU-0029767 has been utilized in preclinical studies to investigate the therapeutic potential of M4 receptor modulation in various neurological disorders, including schizophrenia, Parkinson's disease, and Alzheimer's disease. Its ability to modulate dopaminergic and cholinergic signaling pathways makes it a valuable tool in understanding the pathophysiology of these conditions.
Safety and Toxicology[edit | edit source]
While VU-0029767 has shown promise in research settings, its safety profile in humans has not been fully established. Preclinical studies in animal models are necessary to evaluate its potential side effects and toxicity before considering clinical trials.
Also see[edit | edit source]
- Muscarinic acetylcholine receptor
- Allosteric modulator
- G protein-coupled receptor
- Neurotransmitter
- Schizophrenia
- Parkinson's disease
- Alzheimer's disease
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
